Answers are grounded in this paper and cite their sources.
Peptide and protein synthesis, as well as bioconjugation, are increasingly important for developing site-selective modifications in biomedical applications. Herein, we report a strategy that combines the Passerini multicomponent reaction and peptiligase-mediated ligations for the selective bio-conjugation of peptide C-termini. The Passerini reaction, performed under aqueous acidic buffer conditions, ensures chemoselectivity for the carboxylic acids, while the subsequent enzymatic ligation selectively targets the functionalized C-terminal substrates. We demonstrated this approach on a diverse set of peptides while incorporating various isocyanides and aldehydes/ketones and successfully achieved ligations. By combining the Passerini reaction with enzymatic selectivity, this method provides a versatile and efficient platform for site-selective C-terminal modification, expanding the toolkit for peptide and protein modifications and synthesis. • Functionalization and subsequent ligation of unprotected peptides • Chemoselective Passerini functionalization of carboxylic acids on peptides • Use of aqueous buffer conditions in all steps • Regio- and diastereoselective enzymatic ligation at the C-terminus Hanssens et al. present a selective bio-conjugation strategy for peptide C-termini, combining the Passerini multicomponent reaction and chemo-enzymatic peptide synthesis (CEPS). Aqueous acidic buffer conditions ensure chemoselectivity for carboxylic acids, followed by regioselective enzymatic ligation at the C-termini. This approach opens new avenues for site-selective peptide and protein modifications.
No takes yet. Share an insight, caveat, or question.
Hanssens et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: